HIGH SERUM LEVELS OF SOLUBLE CD25 AND SOLUBLE CD23 IN EARLY-STAGE B-CELL - CORRELATION WITH CLINICAL CHARACTERISTICS PREDICTIVE FOR PROGRESSIVE DISEASE

被引：0
|
作者：
KNAUF, WU [1 ]
ZEIGMEISTER, B [1 ]
LANGENMAIER, I [1 ]
RAGHAVACHAR, A [1 ]
EMMERICH, B [1 ]
THIEL, E [1 ]
机构：
[1] FREE UNIV BERLIN,KLINIKUM STEGLITZ,W-1000 BERLIN 45,GERMANY
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A569 / A569
页数：1
相关论文
共 50 条
  • [41] Serum-Soluble CD163 Levels as a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma Treated with Chemoimmunotherapy
    Koudouna, Aspasia
    Gkioka, Annita Ioanna
    Gkiokas, Alexandros
    Tryfou, Thomai M.
    Papadatou, Mavra
    Alexandropoulos, Alexandros
    Bartzi, Vassiliki
    Kafasi, Nikolitsa
    Kyrtsonis, Marie-Christine
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (05)
  • [42] Doubling time of soluble CD23 is a biological marker for disease progression and survival of untreated stage a B-CLL patients: A 10 years follow-up.
    Meuleman, N
    Lagneuax, L
    Dejeneffe, M
    Sarfati, M
    Delforge, A
    Bennani, J
    Bron, D
    BLOOD, 2003, 102 (11) : 352B - 352B
  • [43] EXPRESSION OF LOW-AFFINITY RECEPTOR FOR IGE (FC-EPSILON-RII, CD23) AND IGE-BF (SOLUBLE CD23) RELEASE BY LYMPHOBLASTOID B-CELL LINE RPMI-8866 AND HUMAN PERIPHERAL LYMPHOCYTES OF NORMAL AND ATOPIC DONORS
    BUJANOWSKIWEBER, J
    BRINGS, B
    KNOLLER, I
    PFEIL, T
    KONIG, W
    IMMUNOLOGY, 1989, 66 (04) : 505 - 511
  • [44] SERUM LEVELS OF CD8-ANTIGEN AND SOLUBLE INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    MUSOLINO, C
    DICESARE, E
    ALONCI, A
    ALLEGRA, A
    ORLANDO, A
    GROSSO, P
    SQUADRITO, G
    ACTA HAEMATOLOGICA, 1991, 85 (02) : 57 - 61
  • [45] Serum soluble CD25 may predict the early therapeutic response in pediatric patients with B-cell non-Hodgkin's lymphoma(BNHL)during autologous chimeric antigen receptor T cell(CAR-T) therapy
    Guo, Jing
    Zhang, Yonghong
    Du, Juan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [46] SERUM LEVELS OF SOLUBLE CD30 MOLECULE (KI-1 ANTIGEN) IN HODGKINS-DISEASE - RELATIONSHIP WITH DISEASE-ACTIVITY AND CLINICAL STAGE
    PIZZOLO, G
    VINANTE, F
    CHILOSI, M
    DALLENBACH, F
    JOSIMOVICALASEVIC, O
    DIAMANTSTEIN, T
    STEIN, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (02) : 282 - 284
  • [47] Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia
    Eisterer, W
    Bechter, O
    Söderberg, O
    Nilsson, K
    Terol, M
    Greil, R
    Thaler, J
    Herold, M
    Finke, L
    Günthert, U
    Montserrat, E
    Stauder, R
    LEUKEMIA RESEARCH, 2004, 28 (10) : 1043 - 1051
  • [48] Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology
    Akin, C
    Schwartz, LB
    Kitoh, T
    Obayashi, H
    Worobec, AS
    Scott, LM
    Metcalfe, DD
    BLOOD, 2000, 96 (04) : 1267 - 1273
  • [49] Expanded CD28-/CD11b+subsets among CD8+T cells predicts more rapid disease progression in early-stage B-cell chronic lymphocytic leukemia
    Bjork, RL
    McDaniel, PR
    Saven, A
    Bjork, RL
    CYTOMETRY, 2000, 42 (05): : 312 - 312
  • [50] High levels of soluble CD25 in COVID-19 severity suggest a divergence between anti-viral and pro-inflammatory T-cell responses
    Xie, Min
    Yunis, Joseph
    Yao, Yin
    Shi, Jing
    Yang, Yang
    Zhou, Pengcheng
    Liang, Kaili
    Wan, Yanmin
    Mehdi, Ahmed
    Chen, Zhian
    Wang, Naiqi
    Xu, Shuyun
    Zhou, Min
    Yu, Muqing
    Wang, Ke
    Tao, Yu
    Zhou, Ying
    Li, Xiaochen
    Liu, Xiansheng
    Yu, Xiao
    Wei, Yunbo
    Liu, Zheng
    Sprent, Jonathan
    Yu, Di
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (02)
12345